Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Post by toinv261on Jun 08, 2014 4:05pm
295 Views
Post# 22641300

RVX Management Satisfaction Survey

RVX Management Satisfaction SurveyHi folks.

Just for kicks I put together a very brief survey, 5 questions, for posters and readers on Stockhouse. I picked questions that seemed reflective of comment themes. The study will give us a score on communications, management competence and rate of progress of RVX.

Keep in mind it is self selecting, non random and not necessarily representative of the broad populatiion of shareholders. It is a test and will close out at the 1st 100 responders. It's fine by me if insiders participate.

That being said it will give us some sort of glimpse at opinions. I'm sure it will not have any influence at RVX perhaps with the exception of improving communications.

Individual results will not be revealled. Only aggregate findings will be published.

Normally in my business I sub-contract this type of work out SO I HOPE IT WORKS. If you go to the following link https://www.surveymonkey.com/s/79NWLRH it should take you to the survey.

If it doesn't work I'll have a bit more egg on my face and a good laugh then I'll try to figure it out.

I didn't pre-test it because it's Sunday and I'm going to my dock to BBQ steak, drink wine and watch the wakeboarders.

Let's hope next week brings some news.

GLTA and cheers.
Toinv


Bullboard Posts